SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-23-005016
Filing Date
2023-03-16
Accepted
2023-03-16 16:30:30
Documents
1
Period of Report
2022-04-21

Document Format Files

Seq Description Document Type Size
1 form4a-03162023_040302.html 4/A  
1 form4a-03162023_040302.xml 4/A 2770
  Complete submission text file 0001415889-23-005016.txt   4062
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
MAHON PAUL A (Reporting) CIK: 0001231589 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-26301 | Film No.: 23739239